Restore energy, clarity, and wellbeing with expert local support from Manor Chemist Still have a Question
GHK-Cu may support hair growth in early thinning by feeding follicles through new blood vessels, blocking a shrinking signal called TGF-beta, and supporting the cells that drive new growth
These medications must be taken on a schedule, on the same day each week
Symptoms may include: Chronic nausea Vomiting Early fullness Abdominal bloating In severe cases, it can lead to dehydration or malnutrition
Currently available GLP-1 receptor agonists in the UK include: Exenatide (short-acting and extended-release formulations) - licensed for type 2 diabetes Liraglutide (once-daily injection) - licensed for type 2 diabetes (Victoza) and separately for weight management (Saxenda 3mg) Dulaglutide (once-weekly injection) - licensed for type 2 diabetes, including cardiovascular risk reduction in those with established cardiovascular disease or multiple risk factors Semaglutide (once-weekly injection and oral formulation) - licensed for type 2 diabetes (Ozempic, Rybelsus) and separately for weight management (Wegovy 2.4mg) A related but distinct medication is tirzepatide (once-weekly injection), which is a dual GIP/GLP-1 receptor agonist licensed for type 2 diabetes management
